A retrospective study of rituximab with high-dose methotrexate in patients with primary central nervous system lymphoma.
Phase of Trial: Phase IV
Latest Information Update: 14 Jun 2016
At a glance
- Drugs Methotrexate (Primary) ; Rituximab (Primary)
- Indications CNS cancer; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 14 Jun 2016 New trial record